J Vlasak
Overview
Explore the profile of J Vlasak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
695
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spirin V, Runnel K, Vlasak J, Viner I, Barrett M, Ryvarden L, et al.
Stud Mycol
. 2024 Apr;
107:149-249.
PMID: 38600960
Based on seven- and three-gene datasets, we discuss four alternative approaches for a reclassification of , . After taking into account morphological diversity in the family, we argue in favour...
2.
Miettinen O, Vlasak J, Larsson E, Vlasak Jr J, Seelan J, Hernawati , et al.
Fungal Syst Evol
. 2024 Mar;
12:271-322.
PMID: 38455955
is a small family of polypores and hydnoid fungi in the order (). The family consists of white-rot fungi, some of which are serious tree pathogens. Combining morphological evidence with...
3.
Sun Y, Xing J, He X, Wu D, Song C, Liu S, et al.
Stud Mycol
. 2022 Sep;
101:287-415.
PMID: 36059897
is one of the main families of macrofungi since species in the family are both ecologically and economically important. The double-walled basidiospores with ornamented endospore walls are the characteristic features...
4.
Miettinen O, Vlasak J, Rivoire B, Spirin V
Fungal Syst Evol
. 2020 Jun;
1:101-129.
PMID: 32490363
Taxonomy of the complex is revised based on morphology and two genetic markers, ITS and . In total, we recognize 24 species, multiplying the known species diversity in the complex....
5.
Pejcoch M, Pazdiora P, Eiselt J, Hajek V, Vesela E, Vlasak J, et al.
Epidemiol Mikrobiol Imunol
. 2010 Nov;
59(1):48-51.
PMID: 21105569
A total of 348 serum samples were collected from 301 hemodialysis patients with chronic renal failure of four healthcare settings in Western Bohemia. The sera were screened for the presence...
6.
Vlasak J, Ionescu R
Curr Pharm Biotechnol
. 2008 Dec;
9(6):468-81.
PMID: 19075686
The expanding field of monoclonal antibody-based pharmaceuticals has triggered increased interest in analytical characterization of these large proteins and in understanding of their heterogeneity and degradation pathways. As a result,...
7.
Vozehova S, Zikmundova K, Zavazalova H, Zaremba V, Vlasak J
Acta Med Austriaca
. 2003 May;
30(2):48-50.
PMID: 12752088
Trends in primary health care consumption were monitored in the elderly (60 or more years of age). Respondents (5162) were picked by random mechanical selection. They were monitored for a...
8.
Hofmann-Lehmann R, Vlasak J, Rasmussen R, Jiang S, Li P, Baba T, et al.
J Med Primatol
. 2002 Aug;
31(3):109-19.
PMID: 12190851
Simian-human immunodeficiency viruses (SHIV) allow the evaluation of antiviral strategies that target the envelope glycoproteins of the human immunodeficiency virus 1 (HIV-1) in macaques. We previously protected neonates from oral...
9.
Rasmussen R, Montefiori D, Li P, Liska V, Vlasak J, Baba T, et al.
J Med Primatol
. 2002 Jun;
31(1):40-60.
PMID: 12076047
Newborn macaques were vaccinated against a chimeric simian human immunodeficiency (SHIV) virus, SHIV-vpu+, by DNA priming and boosting with homologous HIV-1 gp160. Following SHIV-vpu+ challenge, containment of infection was observed...
10.
Merta M, Sobotova D, Zahalkova J, Bitterova Z, Jirka T, Knetl P, et al.
Sb Lek
. 2002 Feb;
102(1):41-52.
PMID: 11830918
Treatment of anaemia of renal origin by recombinant erythropoietin (EPO) is well established and is considered to be an integral part of therapy in patients with chronic renal failure. An...